VEGF Trap-Eye: Additional Phase II data

Additional data from the double-blind, international Phase II DA VINCI trial in 219 patients showed that all 4 doses of intravitreal VEGF Trap-Eye maintained significant improvements from

Read the full 275 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE